The Nutshell

» cancer and culture

Daily News Roundup

Most Recent

image: Direct-to-Consumer Liquid Biopsy

Direct-to-Consumer Liquid Biopsy

By | September 13, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Study: Short Headlines Get More Citations

Study: Short Headlines Get More Citations

By | August 27, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Influential Cancer Biologist Dies

Influential Cancer Biologist Dies

By | August 24, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Resveratrol’s Low-Dose Anticancer Effect

Resveratrol’s Low-Dose Anticancer Effect

By | July 31, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: The Death Toll Tied to Sweet Drinks

The Death Toll Tied to Sweet Drinks

By | July 1, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

7 Comments

image: Keeping Science Pubs Clean

Keeping Science Pubs Clean

By | June 29, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech